The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion

This publication has 27 references indexed in Scilit:

• An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK
  Health Technology Assessment, 2016
• Exchange protein directly activated by cyclic AMP (EPAC) activation reverses neutrophil dysfunction induced by β2-agonists, corticosteroids, and critical illness
  Journal of Allergy and Clinical Immunology, 2016
• Anti-Donor HLA Class I Antibodies
  Transplantation, 2013
• Normothermic Ex Vivo Lung Perfusion in Clinical Lung Transplantation
  New England Journal of Medicine, 2011
• Neutrophil kinetics in health and disease
  Trends in Immunology, 2010
• Interleukin-1β is prominent in the early pulmonary inflammatory response after hepatic injury
  Surgery, 2005
• Pulmonary Transplantation: the role of brain death in donor lung injury
  Transplantation, 2003
• The role of proinflammatory cytokines in lung ischemia-reperfusion injury
  The Journal of Thoracic and Cardiovascular Surgery, 2003
• Interleukin-8 Release during Early Reperfusion Predicts Graft Function in Human Lung Transplantation
  American Journal of Respiratory and Critical Care Medicine, 2002
• Interleukin-1 in Ischemia-Reperfusion Acute Lung Injury
  American Journal of Respiratory and Critical Care Medicine, 1997